Spotted  ||| S:0 E:8 ||| JJ
fever  ||| S:8 E:14 ||| NN
group  ||| S:14 E:20 ||| NN
rickettsiae ||| S:20 E:31 ||| NNS
:  ||| S:31 E:33 ||| :
a  ||| S:33 E:35 ||| DT
brief  ||| S:35 E:41 ||| JJ
review  ||| S:41 E:48 ||| NN
and  ||| S:48 E:52 ||| CC
a  ||| S:52 E:54 ||| DT
Canadian  ||| S:54 E:63 ||| JJ
perspective  ||| S:63 E:75 ||| NN
Spotted  ||| S:75 E:83 ||| VBN
fever  ||| S:83 E:89 ||| NN
group  ||| S:89 E:95 ||| NN
rickettsioses  ||| S:95 E:109 ||| NNS
( ||| S:109 E:110 ||| -LRB-
SFGR ||| S:110 E:114 ||| NNP
)  ||| S:114 E:116 ||| -RRB-
are  ||| S:116 E:120 ||| VBP
infections  ||| S:120 E:131 ||| VBN
caused  ||| S:131 E:138 ||| VBN
by  ||| S:138 E:141 ||| IN
established  ||| S:141 E:153 ||| JJ
and  ||| S:153 E:157 ||| CC
emerging  ||| S:157 E:166 ||| VBG
human  ||| S:166 E:172 ||| JJ
pathogens  ||| S:172 E:182 ||| JJ
worldwide ||| S:182 E:191 ||| NN
.  ||| S:191 E:193 ||| .
These  ||| S:193 E:199 ||| DT
rickettsial  ||| S:199 E:211 ||| JJ
agents  ||| S:211 E:218 ||| NNS
are  ||| S:218 E:222 ||| VBP
transmitted  ||| S:222 E:234 ||| VBN
to  ||| S:234 E:237 ||| TO
humans  ||| S:237 E:244 ||| NNS
via  ||| S:244 E:248 ||| IN
arthropods  ||| S:248 E:259 ||| NN
and  ||| S:259 E:263 ||| CC
may  ||| S:263 E:267 ||| MD
result  ||| S:267 E:274 ||| VB
in  ||| S:274 E:277 ||| IN
mild  ||| S:277 E:282 ||| JJ
to  ||| S:282 E:285 ||| TO
severe  ||| S:285 E:292 ||| JJ
and  ||| S:292 E:296 ||| CC
potentially  ||| S:296 E:308 ||| RB
fatal  ||| S:308 E:314 ||| JJ
diseases ||| S:314 E:322 ||| NNS
.  ||| S:322 E:324 ||| .
Spotted  ||| S:324 E:332 ||| JJ
fever  ||| S:332 E:338 ||| NN
group  ||| S:338 E:344 ||| NN
rickettsioses  ||| S:344 E:358 ||| NNS
are  ||| S:358 E:362 ||| VBP
characterized  ||| S:362 E:376 ||| VBN
by  ||| S:376 E:379 ||| IN
similar  ||| S:379 E:387 ||| JJ
clinical  ||| S:387 E:396 ||| JJ
features ||| S:396 E:404 ||| NNS
,  ||| S:404 E:406 ||| ,
including  ||| S:406 E:416 ||| VBG
fever ||| S:416 E:421 ||| NN
,  ||| S:421 E:423 ||| ,
rash ||| S:423 E:427 ||| NN
,  ||| S:427 E:429 ||| ,
headache  ||| S:429 E:438 ||| NN
and  ||| S:438 E:442 ||| CC
myalgias ||| S:442 E:450 ||| NN
,  ||| S:450 E:452 ||| ,
with  ||| S:452 E:457 ||| IN
the  ||| S:457 E:461 ||| DT
development  ||| S:461 E:473 ||| NN
of  ||| S:473 E:476 ||| IN
an  ||| S:476 E:479 ||| DT
inoculation  ||| S:479 E:491 ||| JJ
eschar  ||| S:491 E:498 ||| NN
in  ||| S:498 E:501 ||| IN
many ||| S:501 E:505 ||| JJ
,  ||| S:505 E:507 ||| ,
but  ||| S:507 E:511 ||| CC
not  ||| S:511 E:515 ||| RB
all  ||| S:515 E:519 ||| DT
cases ||| S:519 E:524 ||| NNS
.  ||| S:524 E:526 ||| .
Endemic  ||| S:526 E:534 ||| JJ
rickettsial  ||| S:534 E:546 ||| JJ
infections  ||| S:546 E:557 ||| NNS
do  ||| S:557 E:560 ||| VBP
occur  ||| S:560 E:566 ||| VB
but  ||| S:566 E:570 ||| CC
are  ||| S:570 E:574 ||| VBP
infrequent  ||| S:574 E:585 ||| VBN
in  ||| S:585 E:588 ||| IN
Canada ||| S:588 E:594 ||| NNP
,  ||| S:594 E:596 ||| ,
in  ||| S:596 E:599 ||| IN
contrast  ||| S:599 E:608 ||| NN
to  ||| S:608 E:611 ||| TO
the  ||| S:611 E:615 ||| DT
United  ||| S:615 E:622 ||| NNP
States ||| S:622 E:628 ||| NNPS
,  ||| S:628 E:630 ||| ,
where  ||| S:630 E:636 ||| WRB
these  ||| S:636 E:642 ||| DT
infections  ||| S:642 E:653 ||| NNS
are  ||| S:653 E:657 ||| VBP
far  ||| S:657 E:661 ||| RB
more  ||| S:661 E:666 ||| RBR
prevalent ||| S:666 E:675 ||| JJ
.  ||| S:675 E:677 ||| .
Travel-associated  ||| S:677 E:695 ||| JJ
rickettsioses ||| S:695 E:708 ||| NN
,  ||| S:708 E:710 ||| ,
however ||| S:710 E:717 ||| RB
,  ||| S:717 E:719 ||| ,
are  ||| S:719 E:723 ||| VBP
being  ||| S:723 E:729 ||| VBG
diagnosed  ||| S:729 E:739 ||| VBN
with  ||| S:739 E:744 ||| IN
increasing  ||| S:744 E:755 ||| VBG
frequency  ||| S:755 E:765 ||| NN
in  ||| S:765 E:768 ||| IN
Canadian  ||| S:768 E:777 ||| JJ
travellers  ||| S:777 E:788 ||| NNS
returning  ||| S:788 E:798 ||| VBG
from  ||| S:798 E:803 ||| IN
international  ||| S:803 E:817 ||| JJ
trips  ||| S:817 E:823 ||| NNS
abroad ||| S:823 E:829 ||| RB
,  ||| S:829 E:831 ||| ,
in  ||| S:831 E:834 ||| IN
particular  ||| S:834 E:845 ||| JJ
in  ||| S:845 E:848 ||| IN
travellers  ||| S:848 E:859 ||| NNS
returning  ||| S:859 E:869 ||| VBG
from  ||| S:869 E:874 ||| IN
Africa ||| S:874 E:880 ||| NNP
.  ||| S:880 E:882 ||| .
The  ||| S:882 E:886 ||| DT
diagnosis  ||| S:886 E:896 ||| NN
of  ||| S:896 E:899 ||| IN
rickettsial  ||| S:899 E:911 ||| JJ
infections  ||| S:911 E:922 ||| NNS
can  ||| S:922 E:926 ||| MD
be  ||| S:926 E:929 ||| VB
challenging  ||| S:929 E:941 ||| JJ
owing  ||| S:941 E:947 ||| NN
to  ||| S:947 E:950 ||| TO
the  ||| S:950 E:954 ||| DT
non-specific  ||| S:954 E:967 ||| JJ
nature  ||| S:967 E:974 ||| NN
of  ||| S:974 E:977 ||| IN
the  ||| S:977 E:981 ||| DT
clinical  ||| S:981 E:990 ||| JJ
symptoms  ||| S:990 E:999 ||| NNS
and  ||| S:999 E:1003 ||| CC
the  ||| S:1003 E:1007 ||| DT
requirement  ||| S:1007 E:1019 ||| NN
for  ||| S:1019 E:1023 ||| IN
specialized  ||| S:1023 E:1035 ||| JJ
testing ||| S:1035 E:1042 ||| NN
.  ||| S:1042 E:1044 ||| .
Serology  ||| S:1044 E:1053 ||| JJ
cannot  ||| S:1053 E:1060 ||| JJ
distinguish  ||| S:1060 E:1072 ||| NN
between  ||| S:1072 E:1080 ||| IN
the  ||| S:1080 E:1084 ||| DT
approximately  ||| S:1084 E:1098 ||| RB
20  ||| S:1098 E:1101 ||| CD
spotted  ||| S:1101 E:1109 ||| JJ
fever  ||| S:1109 E:1115 ||| NN
group  ||| S:1115 E:1121 ||| NN
rickettsial  ||| S:1121 E:1133 ||| NNS
species  ||| S:1133 E:1141 ||| VBP
currently  ||| S:1141 E:1151 ||| RB
known  ||| S:1151 E:1157 ||| VBN
or  ||| S:1157 E:1160 ||| CC
suspected  ||| S:1160 E:1170 ||| VBN
to  ||| S:1170 E:1173 ||| TO
be  ||| S:1173 E:1176 ||| VB
capable  ||| S:1176 E:1184 ||| JJ
of  ||| S:1184 E:1187 ||| IN
causing  ||| S:1187 E:1195 ||| VBG
human  ||| S:1195 E:1201 ||| JJ
infection ||| S:1201 E:1210 ||| NN
.  ||| S:1210 E:1212 ||| .
Molecular  ||| S:1212 E:1222 ||| JJ
testing  ||| S:1222 E:1230 ||| NN
is  ||| S:1230 E:1233 ||| VBZ
required  ||| S:1233 E:1242 ||| VBN
to  ||| S:1242 E:1245 ||| TO
determine  ||| S:1245 E:1255 ||| VB
the  ||| S:1255 E:1259 ||| DT
rickettsial  ||| S:1259 E:1271 ||| JJ
species  ||| S:1271 E:1279 ||| NNS
responsible  ||| S:1279 E:1291 ||| JJ
for  ||| S:1291 E:1295 ||| IN
infection ||| S:1295 E:1304 ||| NN
,  ||| S:1304 E:1306 ||| ,
but  ||| S:1306 E:1310 ||| CC
requires  ||| S:1310 E:1319 ||| VBZ
greater  ||| S:1319 E:1327 ||| JJR
effort  ||| S:1327 E:1334 ||| NN
on  ||| S:1334 E:1337 ||| IN
the  ||| S:1337 E:1341 ||| DT
part  ||| S:1341 E:1346 ||| NN
of  ||| S:1346 E:1349 ||| IN
the  ||| S:1349 E:1353 ||| DT
clinician  ||| S:1353 E:1363 ||| NN
to  ||| S:1363 E:1366 ||| TO
collect  ||| S:1366 E:1374 ||| VB
appropriate  ||| S:1374 E:1386 ||| JJ
samples ||| S:1386 E:1393 ||| NNS
,  ||| S:1393 E:1395 ||| ,
including  ||| S:1395 E:1405 ||| VBG
cutaneous  ||| S:1405 E:1415 ||| JJ
skin  ||| S:1415 E:1420 ||| NN
swabs  ||| S:1420 E:1426 ||| NN
from  ||| S:1426 E:1431 ||| IN
under  ||| S:1431 E:1437 ||| IN
the  ||| S:1437 E:1441 ||| DT
eschar  ||| S:1441 E:1448 ||| NN
or  ||| S:1448 E:1451 ||| CC
skin  ||| S:1451 E:1456 ||| NN
punch  ||| S:1456 E:1462 ||| NN
biopsies  ||| S:1462 E:1471 ||| NNS
of  ||| S:1471 E:1474 ||| IN
the  ||| S:1474 E:1478 ||| DT
eschar  ||| S:1478 E:1485 ||| NN
or  ||| S:1485 E:1488 ||| CC
rash ||| S:1488 E:1492 ||| NN
.  ||| S:1492 E:1494 ||| .
Infections  ||| S:1494 E:1505 ||| NNS
with  ||| S:1505 E:1510 ||| IN
spotted  ||| S:1510 E:1518 ||| JJ
fever  ||| S:1518 E:1524 ||| NN
group  ||| S:1524 E:1530 ||| NN
rickettsiae  ||| S:1530 E:1542 ||| VBZ
likely  ||| S:1542 E:1549 ||| RB
occur  ||| S:1549 E:1555 ||| VB
more  ||| S:1555 E:1560 ||| RBR
commonly  ||| S:1560 E:1569 ||| RB
than  ||| S:1569 E:1574 ||| IN
currently  ||| S:1574 E:1584 ||| RB
recognized  ||| S:1584 E:1595 ||| VBN
and  ||| S:1595 E:1599 ||| CC
should  ||| S:1599 E:1606 ||| MD
be  ||| S:1606 E:1609 ||| VB
considered  ||| S:1609 E:1620 ||| VBN
in  ||| S:1620 E:1623 ||| IN
patients  ||| S:1623 E:1632 ||| NNS
with  ||| S:1632 E:1637 ||| IN
appropriate  ||| S:1637 E:1649 ||| JJ
symptoms  ||| S:1649 E:1658 ||| NNS
and  ||| S:1658 E:1662 ||| CC
exposure  ||| S:1662 E:1671 ||| NN
histories ||| S:1671 E:1680 ||| NN
.  ||| S:1680 E:1682 ||| .
